Generex Biotechnology granted new U.S. drug delivery patent

Patent covers broad claims for the delivery of macromolecules via the buccal cavity of the mouth

18-Aug-2006

Generex Biotechnology Corporation announced that the United States Patent and Trademark Office has granted the Company a new United States Patent entitled Methods of Administering and Enhancing absorption of Pharmaceutical Agents. The patent covers broad claims for the delivery of macromolecules via the buccal cavity of the mouth.

The patent relates to the Company's proprietary methodologies for the production of safe and effective oral formulations for the delivery of macromolecular pharmaceutical agents into the human body via the buccal region of the mouth. The process involves the creation of a stable mixed micellar solution containing the pharmaceutical agent, absorption enhancers, and other excipients. When the solution is introduced to the buccal mucosa, the result is increased bioavailability of the active drug and more rapid onset of action.

Other news from the department research and development

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics